{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:54:25Z","timestamp":1761540865562},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.cld.2008.02.012","type":"journal-article","created":{"date-parts":[[2008,5,9]],"date-time":"2008-05-09T10:00:23Z","timestamp":1210327223000},"page":"277-288","source":"Crossref","is-referenced-by-count":36,"title":["Natural History of Primary Biliary Cirrhosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Marlyn J.","family":"Mayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2008.02.012_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggar","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.012_bib2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/0016-5085(90)90968-7","article-title":"Symptom development and prognosis in primary biliary cirrhosis: a study in two centers","volume":"99","author":"Mitchison","year":"1990","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2008.02.012_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.012_bib4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1055\/s-2005-858281","article-title":"Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis","volume":"43","author":"Leuschner","year":"2005","journal-title":"Z Gastroenterol"},{"issue":"9039","key":"10.1016\/j.cld.2008.02.012_bib5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2008.02.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary biliary cirrhosis: Survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years","volume":"20","author":"Mahl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.012_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365528909092240","article-title":"Primary biliary cirrhosis: clinical features and outcome, with special reference to asymptomatic disease","volume":"24","author":"Nyberg","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.012_bib8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.02.012_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.02.012_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2008.02.012_bib11","first-page":"473","article-title":"Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?","volume":"35","author":"Butler","year":"1995","journal-title":"Biochem Mol Biol Int"},{"issue":"5","key":"10.1016\/j.cld.2008.02.012_bib12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib13","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression of a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.012_bib14","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2008.02.012_bib15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2008.02.012_bib16","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.2005.080317","article-title":"Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort","volume":"55","author":"Jones","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.012_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.012_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Naloxone ameliorates the pruritus of cholestasis: results of a double-blind randomized placebo-controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2008.02.012_bib19","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","article-title":"Long term efficacy of sertraline as a treatment for cholestatic pruritus","volume":"98","author":"Browning","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2008.02.012_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1542-3565(03)00134-4","article-title":"Natural history of pruritus in primary biliary cirrhosis","volume":"1","author":"Talwalkar","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2008.02.012_bib21","first-page":"1840","article-title":"The natural history of abdominal pain associated with primary biliary cirrhosis","volume":"89","author":"Laurin","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2008.02.012_bib22","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/00365520510023215","article-title":"Survival following the development of ascites and\/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model","volume":"40","author":"Chan","year":"2005","journal-title":"Scand J\u00a0Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2008.02.012_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1007193","article-title":"Survival algorithms and outcome analysis in primary biliary cirrhosis","volume":"17","author":"Pasha","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2008.02.012_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.012_bib25","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.510290511","article-title":"Incidence of cancer in primary biliary cirrhosis: the Mayo experience","volume":"29","author":"Nijhawan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib26","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/gut.45.5.756","article-title":"Cancer risk in primary biliary cirrhosis: a study in northern England","volume":"45","author":"Howel","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.cld.2008.02.012_bib27","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/gast.2002.31880","article-title":"Primary biliary cirrhosis. Incidence and predictive factors of cirrhosis development in ursodiol treated patients","volume":"122","author":"Corpechot","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2008.02.012_bib28","first-page":"53","article-title":"Time course of histological progression in primary biliary cirrhosis","volume":"23","author":"Locke","year":"1998","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2008.02.012_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.21151","article-title":"Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC","volume":"43","author":"Corpechot","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2008.02.012_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis","volume":"54","author":"Rigapoulou","year":"2005","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2008.02.012_bib32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2008.02.012_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0168-8278(01)00137-4","article-title":"Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?","volume":"35","author":"Corpechot","year":"2001","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2008.02.012_bib34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0168-8278(99)80135-4","article-title":"The tumor necrosis factor-alpha promoter correlates with progression of primary biliary cirrhosis","volume":"30","author":"Tanaka","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.012_bib35","series-title":"Prognostic modeling in primary biliary cirrhosis","author":"Christensen","year":"1999"},{"key":"10.1016\/j.cld.2008.02.012_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.1840100516","article-title":"Extramural cross validation of the Mayo primary biliary cirrhosis survival model established its generalizability","volume":"10","author":"Grambsch","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib38","first-page":"1148","article-title":"Is the mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?","volume":"23","author":"Kilmurry","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2008.02.012_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/hep.1840200120","article-title":"Primary biliary cirrhosis: predication of short term survival based on repeated patient visits","volume":"20","author":"Murtaugh","year":"1994","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2008.02.012_bib40","first-page":"222","article-title":"Prognosis in primary biliary cirrhosis. A review","volume":"23","author":"Biagini","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.cld.2008.02.012_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.510300415","article-title":"Is serum bilirubin concentration the only valid prognostic marker in primary biliary cirrhosis?","volume":"30","author":"Krzeski","year":"1999","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2008.02.012_bib42","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2008.02.012_bib43","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"1","author":"Gludd","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2008.02.012_bib44","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2008.02.012_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2008.02.012_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2008.02.012_bib47","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2008.02.012_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2008.02.012_bib49","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2008.02.012_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","author":"Khettry","year":"2003","journal-title":"Liver Transpl"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326108000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T22:57:23Z","timestamp":1546037843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326108000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S1089326108000287"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2008.02.012","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}